GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Average Rating of “Moderate Buy” by Brokerages

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have earned a consensus recommendation of “Moderate Buy” from the fourteen analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $95.46.

A number of brokerages recently issued reports on GEHC. Evercore ISI upped their price target on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a research note on Wednesday, September 18th. JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 target price for the company. Stifel Nicolaus upped their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. Finally, UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price objective for the stock from $84.00 to $74.00 in a report on Thursday, September 26th.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $81.24 on Monday. GE HealthCare Technologies has a one year low of $67.00 and a one year high of $94.55. The firm’s 50 day moving average price is $86.80 and its 200-day moving average price is $83.68. The firm has a market cap of $37.12 billion, a P/E ratio of 22.32, a P/E/G ratio of 2.97 and a beta of 1.07. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. The company had revenue of $4.86 billion during the quarter, compared to analysts’ expectations of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The firm’s revenue was up .9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.99 EPS. As a group, equities research analysts predict that GE HealthCare Technologies will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be issued a $0.035 dividend. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 annualized dividend and a yield of 0.17%. The ex-dividend date is Tuesday, January 14th. GE HealthCare Technologies’s payout ratio is currently 3.30%.

Insider Activity at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.27% of the company’s stock.

Institutional Trading of GE HealthCare Technologies

Large investors have recently modified their holdings of the company. Retirement Systems of Alabama increased its holdings in shares of GE HealthCare Technologies by 7.3% during the third quarter. Retirement Systems of Alabama now owns 100,505 shares of the company’s stock valued at $9,432,000 after purchasing an additional 6,862 shares during the period. Tidal Investments LLC increased its stake in GE HealthCare Technologies by 32.5% in the 3rd quarter. Tidal Investments LLC now owns 23,715 shares of the company’s stock worth $2,226,000 after purchasing an additional 5,819 shares in the last quarter. Wilmington Savings Fund Society FSB raised its holdings in shares of GE HealthCare Technologies by 150.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 11,278 shares of the company’s stock valued at $1,058,000 after acquiring an additional 6,770 shares during the period. World Investment Advisors LLC raised its stake in GE HealthCare Technologies by 44.5% during the 3rd quarter. World Investment Advisors LLC now owns 4,716 shares of the company’s stock valued at $443,000 after purchasing an additional 1,453 shares during the period. Finally, Sanctuary Advisors LLC lifted its stake in GE HealthCare Technologies by 29.6% in the 3rd quarter. Sanctuary Advisors LLC now owns 20,761 shares of the company’s stock worth $1,948,000 after acquiring an additional 4,738 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.